GMIM
BIO icon

General Motors Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

General Motors Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,257
Closed -$305K – 76
2015
Q1 		$305K Buy
+2,257
New +$280K 0.03% 714
2014
Q3 		– Sell
-7,387
Closed -$884K – 934
2014
Q2 		$884K Buy
+7,387
New +$902K 0.07% 320

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

General Motors Investment Management's BIO Position: Q2 2015 in Review

General Motors Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2015, closing a stake of 2,257 shares — an estimated $305K sold.

General Motors Investment Management first reported a position in BIO in Q2 2014 and held it in 2 quarters. The position peaked at $884K in Q2 2014. 225 funds tracked by Wall St. Rank hold BIO as of Q2 2015.

  • General Motors Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2015 after selling out during the quarter.
  • General Motors Investment Management sold 2,257 Bio-Rad Laboratories Class A shares in Q2 2015, an estimated $305K.
  • General Motors Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2014 and held it in 2 quarters.
  • General Motors Investment Management's Bio-Rad Laboratories Class A position peaked at $884K in Q2 2014.
  • 225 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2015.

Based on General Motors Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.